WallStreetZenWallStreetZen

NASDAQ: IMNN
Imunon Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

IMNN past revenue growth

How has IMNN's revenue growth performed historically?
Company
-100%
Industry
71.12%
Market
17.66%
IMNN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IMNN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
IMNN's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

IMNN earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$18.1M
Current Profit Margin
0%

IMNN Return on Equity

Current Company
-165.5%
Current Industry
22.9%
Current Market
33.8%
IMNN's Return on Equity (-165.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when IMNN announces earnings.

IMNN Return on Assets

Current Company
-102.5%
Current Industry
3.5%
IMNN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

IMNN Return on Capital Employed

Current Company
-419.64%
Current Industry
21.4%
IMNN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IMNN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
IMNN$0.00-$18.66M-$18.08M-100.00%N/A
INDP$0.00-$15.75M-$15.75MN/AN/A
GLTO$0.00-$24.61M-$25.43MN/AN/A
IMRN$3.34MN/A-$4.72M+14.22%N/A
IBIO$50.00k-$21.76M-$23.16M-47.99%N/A
View Top Biotech Stocks

IMNN earnings dates

Next earnings date
Nov 12, 2024

Imunon Earnings & Revenue FAQ

What were IMNN's earnings last quarter?

On Invalid Date, Imunon (NASDAQ: IMNN) reported Q2 2024 earnings per share (EPS) of -$0.51, up 16.39% year over year. Total Imunon earnings for the quarter were -$4.79 million. In the same quarter last year, Imunon's earnings per share (EPS) was -$0.61.

If you're new to stock investing, here's how to buy Imunon stock.

What was IMNN's earnings growth in the past year?

As of Q3 2024, Imunon's earnings has grown year over year. Imunon's earnings in the past year totalled -$18.08 million.

What is IMNN's earnings date?

Imunon's earnings date is Invalid Date. Add IMNN to your watchlist to be reminded of IMNN's next earnings announcement.

What was IMNN's revenue last quarter?

On Invalid Date, Imunon (NASDAQ: IMNN) reported Q2 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Imunon's revenue was $0.00.

What was IMNN's revenue growth in the past year?

As of Q3 2024, Imunon's revenue has grown -100% year over year. This is 171.12 percentage points lower than the US Biotechnology industry revenue growth rate of 71.12%. Imunon's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.